Tag: Dermatology

Nevisense Electrical Impedance Spectroscopy to Test Lesions Before Biopsy for Melanoma

SciBase, a Swedish firm, won FDA approval to introduce its Nevisense system to help dermatologists assess suspect cutaneous lesions that may be melanoma tumors. Unlike many technologies that have been attempted to characterize cancerous lesions, this one uses electrical impedance rather than optical methods. The system delivers electric current at different frequencies through the lesion using […]

WONTECH Picocare Laser System for Tattoo Removal Cleared by FDA

Korean company WONTECH won FDA clearance to introduce its Picocare laser-based tattoo removal device. The system relies on a Nd:YAG (neodymium-doped yttrium aluminium garnet) laser that generates light in a choice of four different wavelengths and delivers it in pulses lasting only 750 picoseconds (.00000000075 s). The laser light is able to break up tattoos of […]

Vectra WB360 Whole-Body Skin Lesion Mapping System

Canfield Scientific (Parsippany, NJ) have recently installed the first commercial Vectra WB360 whole-body skin lesion mapping system. Skin cancer can develop from lesions on the skin, such as moles. If a lesion begins to change shape or size it might be turning cancerous. For people at risk of skin cancer, such as those who have already […]

New Technique Spots Pheomelanin in Pale Patients at Risk of Dangerous Melanoma

People with light colored skin, and particularly orange tinted redheads, have high levels of pheomelanin, a type of melanin, in their skin. It is correlated with amelanotic melanoma, a nasty skin cancer that’s difficult not only to treat, but to detect in the first place. This is because pheomelanin within amelanotic melanomas blends in with healthy skin, […]

This post New Technique Spots Pheomelanin in Pale Patients at Risk of Dangerous Melanoma appeared first on Medgadget.

Artificial Intelligence System to Diagnose Skin Cancer: Interview with Stanford Scientist Andre Esteva

Scientists at Stanford University have developed a deep convolutional neural network that can diagnose skin cancer by examining images of skin lesions. Skin cancer is the most common human cancer, and one in five Americans will be diagnosed with it at some point in their lives. At present, skin cancer is primarily diagnosed through an […]

This post Artificial Intelligence System to Diagnose Skin Cancer: Interview with Stanford Scientist Andre Esteva appeared first on Medgadget.

The First EMR to Integrate with Watson (INTERVIEW)

At Medgadget we’re optimistic about the potential of IBM‘s Watson computer to improve clinical workflow and efficiency, which is why we were excited to learn about the first integration of Watson into an EMR. Modernizing Medicine has staked its claim in a relatively crowded EMR space by focusing on specialty-based medicine, such as dermatology and ophthalmology, as well as offering a structured data framework enabled by their mobile-compatible system. We spoke to the company’s CEO, Dan Cane, last year and decided to follow up with him again to learn more about the Watson integration and recap what the company does for those who have not heard about it.

Shiv Gaglani, Medgadget: What was the impetus for starting Modernizing Medicine?

Read More »

A Specialized and Structured EMR: Interview with Modernizing Medicine Co-Founder and CEO, Daniel Cane

In large part due to 2009′s Health Information Technology for Economic and Clinical Health (HITECH) Act, there has been a proliferation of electronic medical record systems. Many of the largest providers, such as Johns Hopkins and Kaiser Permanente, have seen a consolidation onto large systems like Epic, while many small to middle-sized providers continue to use direct to consumer type systems such as Practice Fusion. These systems are competing for market share and thus have built products that can be used by everyone from family physicians to neurosurgeons, often in a one-size-fits-all fashion.

We recently came across a relatively new EMR called Modernizing Medicine, which had a presence at both TEDMED and CONVERGE this year, that announced today that it received $14 million in equity funding. Their approach is to build focused systems for key specialties, starting with dermatology and moving to opthalmology and even orthopedic and plastic surgery. We had the opportunity to speak with Modernizing Medicine’s CEO and Co-founder, Daniel Cane, who is no stranger to building tech solutions for large industries; as an undergraduate at Cornell in the late 1990s he co-founded Blackboard, the largest learning management system in education.

Read More »